Related Experiment Videos
Practical experience with the design and analysis of a three-armed equivalence study
S Lange1, G Freitag, H J Trampisch
1Department of Medical Informatics, Biometry and Epidemiology, Ruhr University Bochum, Germany. stefan.f.lange@ruhr-uni-bochum.de
European Journal of Clinical Pharmacology
|December 1, 1998
Summary
Therapeutic equivalence of horse chestnut seed extract (HCSE) and compression for chronic venous insufficiency (CVI) was not demonstrated. Compression failed to show superiority over placebo, impacting the assessment of HCSE equivalence.
Area of Science:
- Vascular Medicine
- Clinical Trial Design
- Pharmacoeconomics
Background:
- Therapeutic equivalence trial methodology is underdeveloped compared to bioequivalence studies.
- Chronic venous insufficiency (CVI) management often uses compression therapy, but its efficacy requires robust demonstration.
- Horse chestnut seed extract (HCSE) is a potential treatment for CVI, necessitating rigorous efficacy evaluation.
Purpose of the Study:
- To assess the therapeutic equivalence between HCSE and compression therapy in CVI patients.
- To establish compression therapy's efficacy against placebo as a prerequisite for equivalence testing.
- To address methodological challenges in therapeutic equivalence trials using a three-arm design.
Main Methods:
- A two-stage hypothesis testing approach was employed: (1) compression superiority over placebo, and (2) HCSE non-inferiority to compression.
- Standardized difference irrelevance criteria were set at 0.5 for both statistical tests.
- A three-arm trial design incorporating a placebo group was utilized to manage interpretation complexities.
Main Results:
- Therapeutic equivalence could not be established as compression did not demonstrate relevant superiority to placebo.
- HCSE showed at most irrelevant inferiority compared to compression.
- Exploratory analyses indicated that simultaneous rejection of both null hypotheses was not possible with the given data and equal irrelevance limits.
Conclusions:
- Despite failing to meet the primary objective, the study yielded encouraging results for future research.
- A new study was initiated based on the observed data and findings.
- The concept of a shifted null hypothesis is proposed as more meaningful for clinical trials requiring demonstration of relevant differences, rather than 'no difference'.